Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
在未发生血清转化的免疫抑制患者中,异源载体与同源mRNA COVID-19加强疫苗接种的比较:一项随机对照试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-022-33036-y
Mrak, Daniel; Sieghart, Daniela; Simader, Elisabeth; Tobudic, Selma; Radner, Helga; Mandl, Peter; Göschl, Lisa; Koblischke, Maximilian; Hommer, Nikolaus; Wagner, Angelika; Mayer, Margareta; Schubert, Lorenz; Hartl, Lukas; Kozbial, Karin; Hofer, Philipp; Kartnig, Felix; Hummel, Thomas; Kerschbaumer, Andreas; Deimel, Thomas; Puchner, Antonia; Gudipati, Venugopal; Thalhammer, Renate; Munda, Petra; Uyanik-Ünal, Keziban; Zuckermann, Andreas; Novacek, Gottfried; Reiberger, Thomas; Garner-Spitzer, Erika; Reindl-Schwaighofer, Roman; Kain, Renate; Winkler, Stefan; Smolen, Josef S; Stiasny, Karin; Fischer, Gottfried F; Perkmann, Thomas; Haslacher, Helmuth; Zeitlinger, Markus; Wiedermann, Ursula; Aberle, Judith H; Aletaha, Daniel; Heinz, Leonhard X; Bonelli, Michael